This viewpoint highlights confusion in stereochemical terms of chiral drugs, suggesting clearer labeling and standardized nomenclature.
The Viewpoint addresses the importance of correct designations of stereochemistry in chiral drugs. Sources of confusion typically arise from merging disparate concepts such as handedness, configuration, and chiroptical properties. This Viewpoint recommends the consistent use of configurational labeling, while avoiding ambiguous and context-dependent nomenclature.
No takes yet. Share an insight, caveat, or question.
Concepción et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: